Inventor · disambiguated record
Mickael Guedj
Also filed as: GUEDJ MICKAEL · GUEDJ MICKAËL
8 granted patents·6 pending applications·61 citations·filing 2012–2019
87Inventor score
Top patents by PatentIndex Score
14 records- 0194US8741886B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2012·Granted Jun 3, 2014·20 cites·17 claims
- 0293US8865769B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2012·Granted Oct 21, 2014·15 cites·10 claims
- 0389US9636316B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2015·Granted May 2, 2017·5 cites·15 claims
- 0489US9144558B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2014·Granted Sep 29, 2015·8 cites·42 claims
- 0588US9931326B2Composition comprising torasemide and baclofen for treating neurological disordersPHARNEXT·Filed 2014·Granted Apr 3, 2018·5 cites·6 claims
- 0681US10434109B2Compositions for treating neurological disordersPHARNEXT·Filed 2018·Granted Oct 8, 2019·2 cites·7 claims
- 0781US9820978B2Treatment of cerebral ischemiaCOHEN DANIEL·Filed 2012·Granted Nov 21, 2017·3 cites·18 claims
- 0879US9867837B2Compositions for treating neurological disordersPHARNEXT·Filed 2013·Granted Jan 16, 2018·3 cites·9 claims
- 0969US2020085790A1Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2019·Application pending·0 cites
- 1062US2017231958A1Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2017·Application pending·0 cites
- 1154US2018125867A1Compositions for treating neurological disordersPHARNEXT·Filed 2017·Application pending·0 cites
- 1249US2016195547A1Diagnostic tools for alzheimer's diseasePHARNEXT·Filed 2014·Application pending·0 cites
- 1339US2018275144A1Diagnostic tools for alzheimer's diseasePHARNEXT·Filed 2016·Application pending·0 cites
- 1438US2020306211A1Method for adapting doses of combination therapiesPHARNEXT·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →